297 related articles for article (PubMed ID: 32988398)
1. Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1.
Ye Y; Kuang X; Xie Z; Liang L; Zhang Z; Zhang Y; Ma F; Gao Q; Chang R; Lee HH; Zhao S; Su J; Li H; Peng J; Chen H; Yin M; Peng C; Yang N; Wang J; Liu J; Liu H; Han L; Chen X
Genome Med; 2020 Sep; 12(1):83. PubMed ID: 32988398
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT.
Tao P; Fisher JF; Shi Q; Mobashery S; Schlegel HB
J Phys Chem B; 2010 Jan; 114(2):1030-7. PubMed ID: 20039633
[TBL] [Abstract][Full Text] [Related]
3. Defining the role of mesenchymal stromal cells on the regulation of matrix metalloproteinases in skeletal muscle cells.
Sassoli C; Nosi D; Tani A; Chellini F; Mazzanti B; Quercioli F; Zecchi-Orlandini S; Formigli L
Exp Cell Res; 2014 May; 323(2):297-313. PubMed ID: 24631289
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury.
Hadass O; Tomlinson BN; Gooyit M; Chen S; Purdy JJ; Walker JM; Zhang C; Giritharan AB; Purnell W; Robinson CR; Shin D; Schroeder VA; Suckow MA; Simonyi A; Sun GY; Mobashery S; Cui J; Chang M; Gu Z
PLoS One; 2013; 8(10):e76904. PubMed ID: 24194849
[TBL] [Abstract][Full Text] [Related]
5. Endogenous matrix metalloproteinases 2 and 9 regulate activation of CD4+ and CD8+ T cells.
Benson HL; Mobashery S; Chang M; Kheradmand F; Hong JS; Smith GN; Shilling RA; Wilkes DS
Am J Respir Cell Mol Biol; 2011 May; 44(5):700-8. PubMed ID: 20639459
[TBL] [Abstract][Full Text] [Related]
6. DFT studies of the ring-opening mechanism of SB-3CT, a potent inhibitor of matrix metalloproteinase 2.
Tao P; Fisher JF; Mobashery S; Schlegel HB
Org Lett; 2009 Jun; 11(12):2559-62. PubMed ID: 19445474
[TBL] [Abstract][Full Text] [Related]
7. Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.
Solomon A; Rosenblum G; Gonzales PE; Leonard JD; Mobashery S; Milla ME; Sagi I
J Biol Chem; 2004 Jul; 279(30):31646-54. PubMed ID: 15102849
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia.
Cui J; Chen S; Zhang C; Meng F; Wu W; Hu R; Hadass O; Lehmidi T; Blair GJ; Lee M; Chang M; Mobashery S; Sun GY; Gu Z
Mol Neurodegener; 2012 May; 7():21. PubMed ID: 22587708
[TBL] [Abstract][Full Text] [Related]
9. Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis.
Du HT; Du LL; Tang XL; Ge HY; Liu P
Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1573-1579. PubMed ID: 28669039
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases 2 and 9 are elevated in human preterm laboring uterine myometrium and exacerbate uterine contractility†.
Ulrich CC; Arinze V; Wandscheer CB; Copley Salem C; Nabati C; Etezadi-Amoli N; Burkin HR
Biol Reprod; 2019 Jun; 100(6):1597-1604. PubMed ID: 30951583
[TBL] [Abstract][Full Text] [Related]
11. Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse.
Semple BD; Noble-Haeusslein LJ; Gooyit M; Tercovich KG; Peng Z; Nguyen TT; Schroeder VA; Suckow MA; Chang M; Raber J; Trivedi A
PLoS One; 2015; 10(11):e0143386. PubMed ID: 26588471
[TBL] [Abstract][Full Text] [Related]
12. Testosterone-induced matrix metalloproteinase activation is a checkpoint for neuronal addition to the adult songbird brain.
Kim DH; Lilliehook C; Roides B; Chen Z; Chang M; Mobashery S; Goldman SA
J Neurosci; 2008 Jan; 28(1):208-16. PubMed ID: 18171938
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model.
Shin JA; Kim HS; Vargas A; Yu WQ; Eom YS; Craft CM; Lee EJ
PLoS One; 2016; 11(11):e0167102. PubMed ID: 27893855
[TBL] [Abstract][Full Text] [Related]
14. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma.
Chen X; Wang K; Jiang S; Sun H; Che X; Zhang M; He J; Wen Y; Liao M; Li X; Zhou X; Song J; Ren X; Yi W; Yang J; Chen X; Yin M; Cheng Y
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35347072
[TBL] [Abstract][Full Text] [Related]
15. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.
Chung YM; Khan PP; Wang H; Tsai WB; Qiao Y; Yu B; Larrick JW; Hu MC
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887262
[TBL] [Abstract][Full Text] [Related]
16. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
17. Collagenase IV plays an important role in regulating hair cycle by inducing VEGF, IGF-1, and TGF-β expression.
Hou C; Miao Y; Wang J; Wang X; Chen CY; Hu ZQ
Drug Des Devel Ther; 2015; 9():5373-83. PubMed ID: 26451090
[TBL] [Abstract][Full Text] [Related]
18. Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage.
Hira-Miyazawa M; Nakamura H; Hirai M; Kobayashi Y; Kitahara H; Bou-Gharios G; Kawashiri S
Int J Oncol; 2018 Feb; 52(2):379-388. PubMed ID: 29345283
[TBL] [Abstract][Full Text] [Related]
19. MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat.
Jia F; Yin YH; Gao GY; Wang Y; Cen L; Jiang JY
J Neurotrauma; 2014 Jul; 31(13):1225-34. PubMed ID: 24661104
[TBL] [Abstract][Full Text] [Related]
20. Title: role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease.
Majeed S; Singh P; Sharma N; Sharma S
BMC Infect Dis; 2016 Nov; 16(1):722. PubMed ID: 27899068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
